Skip to content
Clinical Trials – home
FranceBack to France

Clinical trials in Champigny Sur Marne

3 clinical trials in Champigny Sur Marne, France. Every trial is listed in the EU Clinical Trials Register and updated daily.

FranceOur site in FranceEssaisCliniques.fr(opens in a new tab)
Champigny Sur Marne at a glance
3
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

3 trials in Champigny Sur Marne

Open in trial search

Colon cancer

Recruiting

Study on Using Oxaliplatin, Fluorouracil, and Folinic Acid for Treating Stage II Colon Cancer in Patients with Positive Circulating Tumor DNA

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Fluorouracil
  • Sponsor:Centre Hospitalier Universitaire De Dijon

Study Comparing FOLFIRINOX and Cisplatin-Etoposide for Patients with Metastatic Gastroenteropancreatic Neuroendocrine Carcinoma

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Cisplatin
  • Sponsor:Centre Hospitalier Universitaire De Dijon

Study of Pembrolizumab with Drug Combination for Patients with Microsatellite Stable Metastatic Colorectal Cancer with High Immune Infiltrate

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Fondation Franc.Cancerologie Digestive

Other cities in France

The busiest research cities in the country

All 382 cities in France

Clinical research in Champigny Sur Marne

What the registry says about research in the country

01 Breast Cancer Research

Clinical investigations focusing on metastatic breast cancer treatment strategies, specifically targeting patients with ER-positive, HER2-negative breast cancer with visceral metastases.

  • Treatment Comparison Study
  • Hormonal Therapy Evaluation
  • Metastatic Disease Management

The research aims to evaluate the effectiveness of different treatment combinations including hormonal therapy with abemaciclib versus standard chemotherapy.

02 Colorectal Oncology

Innovative research in colon cancer treatment focusing on stage II disease, utilizing advanced diagnostic approaches with circulating tumor DNA analysis.

  • Adjuvant Treatment Optimization
  • Biomarker-Based Therapy
  • Disease-Free Survival Enhancement

The study evaluates treatment decisions based on molecular markers to improve patient outcomes through targeted FOLFOX therapy.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.